Skip to main content
Log in

Therapeutic liver repopulation for phenylketonuria

  • Advances and Challenges in PKU
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Problems with long-term dietary compliance in phenylketonuria (PKU) necessitate the development of alternative treatment approaches. Therapeutic liver repopulation with phenylalanine hydroxylase (PAH)-expressing cells following hepatocyte or haematopoietic stem cell transplantation has been investigated as a possible novel treatment approach for PKU. Successful therapeutic liver repopulation requires both a stimulus for liver regeneration at the time of cell transplantation and a selective growth advantage for the PAH+ donor cells. Unfortunately, wild-type PAH+ hepatocytes do not enjoy any growth advantage over PAH− cells. Successful correction of hyperphenylalaninemia following therapeutic liver repopulation has been accomplished only in an animal model that yields a selective advantage for the donor cells. Haematopoietic stem cell (HSC)-mediated therapeutic liver repopulation has not been reported in any hyperphenylalaninemic system, and the success of HSC-mediated liver repopulation for PKU may be limited by the slow kinetics of this approach. If therapeutic liver repopulation is to be employed successfully in humans with PKU, an effective method of providing a selective growth advantage for the donor cells must be developed. If this can be achieved, liver repopulation with 10–20% wild-type hepatocytes will likely completely normalize Phe clearance in individuals with PKU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

EC:

Enzyme Commission

FAH:

Fumarylacetoacetate hydrolase

HSC:

Haematopoietic stem cell

OMIM:

Online Mendelian Inheritance in Man database

PAH:

Phenylalanine hydroxylase

Phe:

Phenylalanine

PKU:

Phenylketonuria

References

  • Abkowitz JL, Sabo KM, Yang Z, Vite CH, Shields LE, Haskins ME (2009) In utero transplantation of monocytic cells in cats with alpha-mannosidosis. Transplantation 88:323–329

    Article  CAS  PubMed  Google Scholar 

  • Allen KJ, Cheah DM, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JF, Ioannou PA, Williamson R (2004) The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant 13:765–773

    Article  PubMed  Google Scholar 

  • Au WY, So JC, Ma SK, Lie AK (2009) Glucose-6-phosphate-dehydrogenase deficiency and haematopoietic stem cell transplantation in Chinese patients. Hong Kong Med J 15(Suppl 3):35–38

    CAS  PubMed  Google Scholar 

  • Aytekin C, Yuksek M, Dogu F, Yagmurlu A, Yildiran A, Fitoz S, Kologlu M, Babacan E, Hershfield MS, Ikinciogullari A (2008) An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication. Pediatr Transplant 12:479–482

    Article  PubMed  Google Scholar 

  • Barfield RC, Kasow KA, Hale GA (2008) Advances in pediatric hematopoietic stem cell transplantation. Cancer Biol Ther 7:1533–1539

    PubMed  Google Scholar 

  • Burlina AB (2004) Hepatocyte transplantation for inborn errors of metabolism. J Inherit Metab Dis 27:373–383

    Article  CAS  PubMed  Google Scholar 

  • Cartier N, Aubourg P (2008) Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. Curr Opin Mol Ther 10:471–478

    CAS  PubMed  Google Scholar 

  • Christensen HN (1982) Interorgan amino acid nutrition. Physiol Rev 62:1193–1233

    CAS  PubMed  Google Scholar 

  • Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S, Arya R, Wade JJ, Verma A, Heaton ND, Rela M, Mieli-Vergani G (2004) Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78:1812–1814

    Article  PubMed  Google Scholar 

  • Di Campli C, Gasbarrini G, Gasbarrini A (2003) Review article: a medicine based on cell transplantation-is there a future for treating liver diseases? Aliment Pharmacol Ther 18:473–480

    Article  PubMed  Google Scholar 

  • Duncan AW, Dorrell C, Grompe M (2009) Stem cells and liver regeneration. Gastroenterology 137:466–481

    Article  PubMed  Google Scholar 

  • Enns GM, Millan MT (2008) Cell-based therapies for metabolic liver disease. Mol Genet Metab 95:3–10

    Article  CAS  PubMed  Google Scholar 

  • Enquist IB, Nilsson E, Mansson JE, Ehinger M, Richter J, Karlsson S (2009) Successful low-risk hematopoietic cell therapy in a mouse model of type 1 Gaucher disease. Stem Cells 27:744–752

    Article  CAS  PubMed  Google Scholar 

  • Faraci M, Morreale G, Boeri E, Lanino E, Dallorso S, Dini G, Scuderi F, Cohen A, Cappelli B (2008) Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria. Pediatr Transplant 12:117–120

    Article  CAS  PubMed  Google Scholar 

  • Fitzpatrick AS, Loughrey CM, Johnston P, McKee S, Spence W, Flynn P, Jones FG, Morrow JI (2008) Haematopoietic stem-cell transplant for adult cerebral adrenoleukodystrophy. Eur J Neurol 15:e21–e22

    Article  CAS  PubMed  Google Scholar 

  • Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338:1422–1426

    Article  CAS  PubMed  Google Scholar 

  • Grompe M, Lindstedt S, al-Dhalimy M, Kennaway NG, Papaconstantinou J, Torres-Ramos CA, Ou CN, Finegold M (1995) Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nature Genetics 10:453–460

    Article  CAS  PubMed  Google Scholar 

  • Guha C, Parashar B, Deb NJ, Garg M, Gorla GR, Singh A, Roy-Chowdhury N, Vikram B, Roy-Chowdhury J (2002) Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 36:354–362

    Article  PubMed  Google Scholar 

  • Hamman K, Clark H, Montini E, Al-Dhalimy M, Grompe M, Finegold M, Harding CO (2005) Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria. Mol Ther 12:337–344

    Article  CAS  PubMed  Google Scholar 

  • Hansen K, Horslen S (2008) Metabolic liver disease in children. Liver Transpl 14:713–733

    Article  PubMed  Google Scholar 

  • Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K, James DC, Lucas CF, Rogers TR, Benson PF, Tansley LR, Patrick AD, Mossman J, Young EP (1981) Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2:709–712

    Article  CAS  PubMed  Google Scholar 

  • Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262–1267

    Article  PubMed  Google Scholar 

  • Irani AN, Malhi H, Slehria S, Gorla GR, Volenberg I, Schilsky ML, Gupta S (2001) Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease. Mol Ther 3:302–309

    Article  CAS  PubMed  Google Scholar 

  • Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, Roy-Chowdhury J, Roy-Chowdhury N (2008) Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1. Transplantation 85:1253–1260

    Article  CAS  PubMed  Google Scholar 

  • Joseph B, Kapoor S, Schilsky ML, Gupta S (2009) Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model. Hepatology 49:1616–1624

    Article  CAS  PubMed  Google Scholar 

  • Kocken JM, Borel Rinkes IH, Bijma AM, de Roos WK, Bouwman E, Terpstra OT, Sinaasappel M (1996) Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model. Transplantation 62:358–364

    Article  CAS  PubMed  Google Scholar 

  • Laconi E, Laconi S (2002) Principles of hepatocyte repopulation. Semin Cell Dev Biol 13:433–438

    Article  PubMed  Google Scholar 

  • Lee B, Dennis JA, Healy PJ, Mull B, Pastore L, Yu H, Aguilar-Cordova E, O'Brien W, Reeds P, Beaudet AL (1999) Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia. Proc Natl Acad Sci USA 96:3981–3986

    Article  CAS  PubMed  Google Scholar 

  • Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH, Kim JW, Park HY, Lee SY, Lee HH, Park JW, Kim SY, Yoon HH, Jung DH, Choe YH, Lee SK (2007) Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant 16:629–637

    PubMed  Google Scholar 

  • Lim ZY, Ho AY, Abrahams S, Fensom A, Aldouri M, Pagliuca A, Shaw C, Mufti GJ (2008) Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease. Bone Marrow Transplant 41:831–832

    Article  CAS  PubMed  Google Scholar 

  • Lysy PA, Najimi M, Stephenne X, Bourgois A, Smets F, Sokal EM (2008) Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol 14:3464–3470

    Article  PubMed  Google Scholar 

  • Malm G, Gustafsson B, Berglund G, Lindstrom M, Naess K, Borgstrom B, von Dobeln U, Ringden O (2008) Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT). Acta Paediatr 97:1108–1112

    Article  PubMed  Google Scholar 

  • Matas AJ, Sutherland DE, Steffes MW, Mauer SM, Sowe A, Simmons RL, Najarian JS (1976) Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 192:892–894

    Article  CAS  PubMed  Google Scholar 

  • Meyburg J, Alexandrova K, Barthold M, Kafert-Kasting S, Schneider AS, Attaran M, Hoerster F, Schmidt J, Hoffmann GF, Ott M (2009) Liver cell transplantation: basic investigations for safe application in infants and small children. Cell Transplant 18:777–786

    Article  PubMed  Google Scholar 

  • Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P, Meroni M, Giron G, Burlina AB (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317–318

    Article  PubMed  Google Scholar 

  • Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou CN, Finegold M, Grompe M (1996) Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nature Genet 12:266–273

    Article  CAS  PubMed  Google Scholar 

  • Park SM, Vo K, Lallier M, Cloutier AS, Brochu P, Alvarez F, Martin SR (2006) Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson's disease. Cell Transplant 15:13–22

    Article  CAS  PubMed  Google Scholar 

  • Polgreen LE, Tolar J, Plog M, Himes JH, Orchard PJ, Whitley CB, Miller BS, Petryk A (2008) Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplant 41:1005–1011

    Article  CAS  PubMed  Google Scholar 

  • Prasad VK, Kurtzberg J (2008) Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant 41:99–108

    Article  CAS  PubMed  Google Scholar 

  • Puppi J, Tan N, Mitry RR, Hughes RD, Lehec S, Mieli-Vergani G, Karani J, Champion MP, Heaton N, Mohamed R, Dhawan A (2008) Hepatocyte transplantation followed by auxiliary liver transplantation-a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 8:452–457

    Article  CAS  PubMed  Google Scholar 

  • Ramsubir S, Nonaka T, Girbes CB, Carpentier S, Levade T, Medin JA (2008) In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease. Mol Genet Metab 95:133–141

    Article  CAS  PubMed  Google Scholar 

  • Reyes J, Rubenstein W, Mieles L, Strom SC, Tobin R, Trucco M (1996) The use of cultured hepatocyte infusion via the portal vein for the treatment of ornithine transcarbamoylase deficiency by transplantation of enzymatically competent ABO/Rh-matched cells. Hepatology 24:308A

    Article  Google Scholar 

  • Rovelli AM (2008) The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update. Bone Marrow Transplant 41(Suppl 2):S87–S89

    Article  PubMed  Google Scholar 

  • Sauer M, Meissner B, Fuchs D, Gruhn B, Kabisch H, Erttmann R, Suttorp M, Beilken A, Luecke T, Welte K, Grigull L, Sykora KW (2009) Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005. Bone Marrow Transplant 43:375–381

    Article  CAS  PubMed  Google Scholar 

  • Shi Z, Liang XL, Lu BX, Pan SY, Chen X, Tang QQ, Wang Y, Huang F (2005) Diminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation. World J Gastroenterol 11:3691–3695

    CAS  PubMed  Google Scholar 

  • Skvorak KJ, Paul HS, Dorko K, Marongiu F, Ellis E, Chace D, Ferguson C, Gibson KM, Homanics GE, Strom SC (2009a) Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther 17:1266–1273

    Article  CAS  PubMed  Google Scholar 

  • Skvorak KJ, Hager EJ, Arning E, Bottiglieri T, Paul HS, Strom SC, Homanics GE, Sun Q, Jansen EE, Jakobs C, Zinnanti WJ, Gibson KM (2009b) Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim Biophys Acta 1792:1004–1010

    CAS  PubMed  Google Scholar 

  • Smets F, Najimi M, Sokal EM (2008) Cell transplantation in the treatment of liver diseases. Pediatr Transplant 12:6–13

    Article  CAS  PubMed  Google Scholar 

  • Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, Bernard Otte J, Evrard V, Latinne D, Vincent MF, Moser A, Soriano HE (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76:735–738

    Article  PubMed  Google Scholar 

  • Somaraju UR, Tadepalli K (2008) Hematopoietic stem cell transplantation for Gaucher disease. Cochrane Database Syst Rev, CD006974

  • Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, Roy S, Salomon DR, Cherqui S (2009) Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 114:2542–2552

    Article  CAS  PubMed  Google Scholar 

  • Tolar J, Petryk A, Khan K, Bjoraker KJ, Jessurun J, Dolan M, Kivisto T, Charnas L, Shapiro EG, Orchard PJ (2009) Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant 43:21–27

    Article  CAS  PubMed  Google Scholar 

  • Vajro P, Strisciuglio P, Houssin D, Huault G, Laurent J, Alvarez F, Bernard O (1993) Correction of phenylketonuria after liver transplantation in a child with cirrhosis. N Engl J Med 329:363

    Article  CAS  PubMed  Google Scholar 

  • Waelzlein JH, Puppi J, Dhawan A (2009) Hepatocyte transplantation for correction of inborn errors of metabolism. Curr Opin Nephrol Hypertens 18:481–488

    Article  CAS  PubMed  Google Scholar 

  • Weber A, Groyer-Picard MT, Franco D, Dagher I (2009) Hepatocyte transplantation in animal models. Liver Transpl 15:7–14

    Article  PubMed  Google Scholar 

  • Wiederkehr JC, Kondos GT, Pollak R (1990) Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation 50:466–471

    Article  CAS  PubMed  Google Scholar 

  • Wynn RF, Mercer J, Page J, Carr TF, Jones S, Wraith JE (2009a) Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients. J Pediatr 154:135–139

    Article  CAS  PubMed  Google Scholar 

  • Wynn RF, Wraith JE, Mercer J, O'Meara A, Tylee K, Thornley M, Church HJ, Bigger BW (2009b) Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. J Pediatr 154:609–611

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work has been supported by grants from the US National Institute for Diabetes, Digestive, and Kidney Diseases (NIDDK) and the National Heart, Blood, and Lung Institute. The authors take full responsibility for the content of this meeting report but thank Caudex Medical (supported by Serono Symposia International Foundation) for their assistance in preparing the initial draft of this report and collating the comments of authors and any other named contributors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cary O. Harding.

Additional information

Communicated by: Verena Peters

Use of electronic databases: OMIM.

Competing interest: None declared.

Presented at the Serono Symposia International Foundation Meeting, “Advances and Challenges in PKU”, 16–17 January 2009 in Barcelona, Spain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harding, C.O., Gibson, K.M. Therapeutic liver repopulation for phenylketonuria. J Inherit Metab Dis 33, 681–687 (2010). https://doi.org/10.1007/s10545-010-9099-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-010-9099-1

Keywords

Navigation